OLAPLEX Acquires Biotech Company Purvala
Rhea-AI Summary
OLAPLEX (NASDAQ: OLPX), the haircare brand known for its bond-building technology, has announced its first-ever acquisition of Purvala Bioscience, a Boston-based biotech company. Founded in 2020, Purvala specializes in developing bioinspired technologies for health and beauty applications, led by MIT Professor Dr. Bradley Olsen and colleagues.
The strategic acquisition aims to enhance OLAPLEX's product innovation capabilities, combining Purvala's expertise in high-performing molecular development with OLAPLEX's existing patent-protected bond-building technology, Bis-amino. CEO Amanda Baldwin emphasized the company's commitment to scientific breakthroughs and delivering innovative products to their stylist community and customers.
Positive
- First strategic acquisition in company's 10-year history shows commitment to growth
- Access to Purvala's advanced biotech expertise and molecular development capabilities
- Integration with MIT-affiliated research leadership through Dr. Bradley Olsen
- Potential for next-generation product innovation in haircare science
Negative
- No disclosed financial terms or acquisition cost
- Integration risks with first-time acquisition
- Potential R&D timeline uncertainties for new product development
News Market Reaction 9 Alerts
On the day this news was published, OLPX declined 5.19%, reflecting a notable negative market reaction. Argus tracked a trough of -12.0% from its starting point during tracking. Our momentum scanner triggered 9 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $56M from the company's valuation, bringing the market cap to $1.03B at that time.
Data tracked by StockTitan Argus on the day of publication.
Ten years after launch, OLAPLEX’s first acquisition demonstrates its commitment to product innovation
NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced the acquisition of Purvala Bioscience, a Boston-based biotech company. This marks the first acquisition from OLAPLEX since the brand launched over ten years ago with breakthrough product formulations and a new-to-market philosophy around bond-building in haircare.
Purvala is a Boston-based company founded by Drs. Bradley Olsen, Justin Paloni, and colleagues that seeks to develop transformative bioinspired technologies with applications across health and beauty industries. Since its launch in 2020, Purvala has focused on the creation of high-performing molecules inspired by naturally occurring biological structures. In addition to his leadership role at Purvala, Dr. Olsen also serves as a Professor of Chemical Engineering at MIT.
“Since the very beginning, OLAPLEX was founded on the concept of innovation with groundbreaking bond technology that empowered stylists and their clients to achieve transformative results,” said OLAPLEX CEO Amanda Baldwin. “And scientific breakthroughs are what continues to inspire us as we remain committed to delivering the best possible products for our stylist community and our customers. What we’ve accomplished to-date has already left such a meaningful impact on our industry, and we believe that with Purvala we have the potential to create the next generation of disruptive science-backed product innovation alongside our patent-protected bond-building technology, Bis-amino."
For more information, visit Olaplex.com.
About OLAPLEX
OLAPLEX is a foundational health and beauty company powered by breakthrough innovation and the professional hairstylist. Born in the lab and brought to the chair, our products are designed to enable Pros and their clients to achieve their best results and to provide consumers with a holistic healthy hair regimen. Founded in 2014, OLAPLEX revolutionized prestige hair care with its category creating Complete Bond Technology™, which works by protecting, strengthening and relinking all three bonds during and after hair services. Since then, OLAPLEX has expanded into a full suite of hair health formulas. OLAPLEX’s award-winning products are sold globally through an omnichannel model serving the professional, specialty retail, and direct-to-consumer channels.
Forward-Looking Statements
This press release contains forward-looking statements with respect to, among other things, Olaplex's plans for the development of Purvala's technologies; and the potential to create next generation, disruptive science-backed products. These forward-looking statements are subject to a number of risks and uncertainties. Our management cannot predict all risks, nor can we assess the impact of all factors on the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in or implied by any forward-looking statements we may make. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this press release may not occur and actual results could differ materially and adversely from those anticipated in or implied by the forward-looking statements. Factors that could cause actual results to differ materially include: risks and uncertainties related to the development of the Purvala technologies, including the ability to integrate the technologies into next generation Olaplex products; the risk that we may not be able to realize the expected benefits of the acquisition of Purvala; risks related to the ability to further grow and enhance our product offerings for our stylist community and our customers; and other factors described in our filings with the Securities and Exchange Commission (the "SEC"), including under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 4, 2025, Quarterly Reports on Form 10-Q for the period ended March 31, 2025 filed with the SEC on May 8, 2025 and the period ended June 30, 2025 filed with the SEC on August 7, 2025, and comparable disclosure in our subsequent filings with the SEC. We will make information available in our annual and quarterly reports and other filings with the SEC. The forward-looking statements in this press release speak only as of the date of this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and we are not able to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law.
Contacts:
Investors:
Michael Oriolo
Vice President, Investor Relations
michael.oriolo@olaplex.com
Financial Media:
Lisa Bobroff
Vice President, Global Communications & Consumer Engagement
lisa.bobroff@olaplex.com
FAQ
What company did OLAPLEX (NASDAQ: OLPX) acquire in August 2025?
Who are the founders of Purvala Bioscience?
What is the strategic importance of OLAPLEX's Purvala acquisition?
When was OLAPLEX's last acquisition before Purvala?
What is OLAPLEX's main technology platform?
